Ask HopeStage to review this study with me
Study ID: NCT07484906. We help you review the study, but cannot decide medical eligibility.
WithdrawnNCT07484906
Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
This study has public registry information. It focuses on suicide prevention and currently lists study information.
SuicidalityDrugFrom 18 Years to 69 Years
Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.
Your next step
The official record does not clearly spell out the visit format, but it appears to be coordinated directly by the research team. Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually having a stable enough treatment background for the study, while common reasons not to take part include active substance or alcohol problems that could affect the results and safety concerns that need urgent care first. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateEstimated: May 1, 2026
- Recruitment status
- Withdrawn
- Estimated enrollment
- Not clearly listed
- Sponsor
- University of New Mexico
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Not clearly listed
- Age range
- From 18 Years to 69 Years
- Official registry ID
- NCT07484906
- Official title
- Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
- Official source
- Official registry link
Want help reviewing this study?
Study ID: NCT07484906. We help you review the study, but cannot decide medical eligibility.
For you
Taking part may give access to a new approach being evaluated.
It requires regular visits and structured follow-up.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring behavioral or lifestyle intervention for people with suicide prevention. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.
Do I need to want to stop or reduce tobacco use to participate?
The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
What practical constraints should I expect?
The likely practical burden appears high. Things to check include long follow-up or multiple visits, medical follow-up. Ask the study team about duration, visits, possible compensation, data access, and what happens if you want to stop.
Who is behind this study?
This study is sponsored by University of New Mexico, which appears to be a university. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The registry indicates that this study is not currently recruiting. Check the official registry for the reason and latest status.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
WithdrawnNCT04807829
Adjunctive CB1 Agonist Nabilone in Inpatients With Active Suicide prevention
This study has public registry information. It focuses on suicide prevention and currently lists study information in the United States.
WithdrawnNCT05427981
Anti-suicidal Effects of Buprenorphine In Depressed Individuals
This study has public registry information. It focuses on depression and currently lists study information in the United States.
WithdrawnNCT03502551
ED Treatment of Suicidal people with Ketamine Infusion
This study has public registry information. It focuses on suicide prevention and currently lists study information in the United States.